RBC Capital Reiterates Outperform on Chimera Investment, Maintains $7 Price Target
RBC Capital analyst Kenneth Lee reiterates Chimera Investment (NYSE:CIM) with a Outperform and maintains $7 price target.
What Does Chimera Investment’s Debt Look Like?
Shares of Chimera Investment Inc. (NYSE:CIM) fell by 3.83% in the past three months. When understanding a companies…
5 REITs With The Highest Paying Dividends: How To Supercharge Your Portfolio
Real estate investment trusts (REITs) have long been a popular investment option for those looking for steady income streams.
Chimera Investment’s Debt Overview
Over the past three months, shares of Chimera Investment Inc. (NYSE:CIM) moved higher by 13.51%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
These 2 Mortgage REITs Have Yields Above 10% And Have Gone Unnoticed Trading At A Steep Discount
The iShares Trust iShares Mortgage Real Estate ETF (BATS: REM) has 50 holdings diversified evenly across small, mid, and large-cap equities, also allocating less than half of its assets to the financial services sector.
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Gainers
Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
